| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.04 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |